Bio

Li He is co-head of our practice in Asia (excluding Japan). A leading adviser to companies in Greater China and across Asia, he has deep experience guiding companies through their most critical milestones, from pre-IPO financing through listing and beyond. He is recognized as a top dealmaker and IPO lawyer in Asia. Over the past two decades, Li advised on more than 50 U.S. IPOs and more than 80 HKEX IPOs, including some of Asia’s most important, complex and groundbreaking deals – approximately 50 of which have won “Best IPO of the Year” awards. He is particularly noted for his understanding of key verticals, from technology to healthcare and pharma to financial institutions. This knowledge can make the difference in resolving the thorniest structural, regulatory and disclosure challenges facing issuers. Chambers ranks Li in Band 1 for equity capital markets in China and quotes a client saying he is “highly experienced, very responsive, knowledgeable and capable of providing solutions.”